tiprankstipranks
Trending News
More News >
Sumitomo Dainippon Pharma Co Ltd (DNPUF)
OTHER OTC:DNPUF
US Market
Advertisement

Sumitomo Dainippon Pharma Co (DNPUF) Income Statement

Compare
8 Followers

Sumitomo Dainippon Pharma Co Income Statement

Last quarter (Q4 2024), Sumitomo Dainippon Pharma Co's total revenue was ¥105.65B, an increase of 32.84% from the same quarter last year. In Q4, Sumitomo Dainippon Pharma Co's net income was ¥2.42B. See Sumitomo Dainippon Pharma Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 21Dec 21
Total Revenue
¥ 398.83B¥ 314.56B¥ 555.54B¥ 515.95B¥ 560.03B
Gross Profit
¥ 245.40B¥ 187.98B¥ 376.63B¥ 378.18B¥ 402.91B
Operating Expenses
¥ 216.59B¥ 542.17B¥ 453.60B¥ 306.95B¥ 342.67B
Depreciation and Amortization
¥ 25.56B¥ 37.77B¥ 41.26B¥ 22.67B¥ 38.35B
EBITDA
¥ 56.67B¥ -281.07B¥ -3.50B¥ 103.11B¥ 124.36B
Operating Income
¥ 28.80B¥ -354.19B¥ -76.98B¥ 71.22B¥ 60.23B
Other Income/Expenses
¥ -11.19B¥ 31.08B¥ 29.06B¥ 6.63B¥ 22.73B
Pretax Income
¥ 17.61B¥ -323.11B¥ -47.92B¥ 77.85B¥ 82.96B
Net Income
¥ 23.63B¥ -314.97B¥ -74.51B¥ 56.22B¥ 56.41B
Per Share Metrics
Basic EPS
¥ 59.49¥ -792.79¥ -187.55¥ 141.50¥ 141.99
Diluted EPS
¥ 59.49¥ -792.79¥ -187.55¥ 141.50¥ 141.99
Weighted Average Shares Outstanding
397.29M 397.29M 397.29M 397.29M 397.29M
Weighted Average Shares Outstanding (Diluted)
397.29M 397.29M 397.29M 397.29M 397.29M
Currency in JPY

Sumitomo Dainippon Pharma Co Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis